Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome association. Gruber, S., Chakravarty, A., Heckbert, S. R., Levenson, M., Martin, D., Nelson, J. C., Psaty, B. M., Pinheiro, S., Reich, C. G., Toh, S., & Walker, A. M. Pharmacoepidemiol Drug Saf, 25(9):973-81, 2016.
Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome association [link]Paper  doi  bibtex   
@article{RN34,
   author = {Gruber, S. and Chakravarty, A. and Heckbert, S. R. and Levenson, M. and Martin, D. and Nelson, J. C. and Psaty, B. M. and Pinheiro, S. and Reich, C. G. and Toh, S. and Walker, A. M.},
   title = {Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome association},
   journal = {Pharmacoepidemiol Drug Saf},
   volume = {25},
   number = {9},
   pages = {973-81},
   ISSN = {1099-1557 (Electronic)
1053-8569 (Linking)},
   DOI = {10.1002/pds.4065},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/27418432
https://onlinelibrary.wiley.com/doi/abs/10.1002/pds.4065},
   year = {2016},
   type = {Journal Article}
}

Downloads: 0